Sana Biotechnology, Inc. (SANA)
3.93
-0.16
(-3.91%)
USD |
NASDAQ |
Aug 28, 16:00
3.925
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Free Cash Flow : -135.06M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -135.06M |
| March 31, 2026 | -133.64M |
| December 31, 2025 | -144.77M |
| September 30, 2025 | -158.85M |
| June 30, 2025 | -185.29M |
| March 31, 2025 | -223.90M |
| December 31, 2024 | -256.58M |
| September 30, 2024 | -274.99M |
| June 30, 2024 | -284.86M |
| March 31, 2024 | -273.64M |
| Date | Value |
|---|---|
| December 31, 2023 | -273.61M |
| September 30, 2023 | -288.28M |
| June 30, 2023 | -291.64M |
| March 31, 2023 | -307.13M |
| December 31, 2022 | -310.93M |
| September 30, 2022 | -345.56M |
| June 30, 2022 | -334.96M |
| March 31, 2022 | -309.80M |
| December 31, 2021 | -280.92M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -93.22M |
| Beam Therapeutics, Inc. | -372.77M |
| Prime Medicine, Inc. | -156.85M |
| Intellia Therapeutics, Inc. | -348.69M |
| Moderna, Inc. | -1.244B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.79M |
| Cash from Investing (Quarterly) | -87.52M |
| Cash from Financing (Quarterly) | 93.58M |
| Free Cash Flow Per Share (Quarterly) | -0.1164 |
| Free Cash Flow to Equity (Quarterly) | -32.82M |
| Free Cash Flow to Firm (Quarterly) | -34.41M |
| Free Cash Flow Yield | -12.40% |